ArticleBritish journal of pharmacology2011

bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.

Thomas E Wooters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.